Skip to main content
. 2017 Aug 18;7:8727. doi: 10.1038/s41598-017-09301-2

Figure 2.

Figure 2

Correlations between the percentage of LINE-1 methylation and IFNβ treatment duration. (A) In IFNβ-treated MS patients. (B) In treated patients without clinical activity: there was a significant negative correlation between LINE-1 methylation and treatment duration. (C) In treated patients with clinical activity there was not a significant correlation.